SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea
· Delayed Price · Currency is KRW 1,508.00
+4.00 (0.27%)
At close: Apr 16, 2025, 3:30 PM KST
SAMSUNG PHARM. Co., LTD. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2010 - 2014 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | 2010 - 2014 |
| Operating Revenue | 44,294 | 46,484 | 41,919 | 47,194 | 42,165 | Upgrade
|
| Other Revenue | - | - | - | 0 | - | Upgrade
|
| Revenue | 44,294 | 46,484 | 41,919 | 47,194 | 42,165 | Upgrade
|
| Revenue Growth (YoY) | -4.71% | 10.89% | -11.18% | 11.93% | 39.21% | Upgrade
|
| Cost of Revenue | - | 37,903 | 36,851 | 38,425 | 30,909 | Upgrade
|
| Gross Profit | 44,294 | 8,580 | 5,069 | 8,770 | 11,256 | Upgrade
|
| Selling, General & Admin | - | 12,228 | 11,708 | 15,001 | 13,703 | Upgrade
|
| Research & Development | - | 377.51 | 938.79 | 898.61 | 296.67 | Upgrade
|
| Other Operating Expenses | 29,465 | 755.65 | 261.64 | 475.91 | 398.1 | Upgrade
|
| Operating Expenses | 29,465 | 13,980 | 12,843 | 15,096 | 13,127 | Upgrade
|
| Operating Income | 14,829 | -5,399 | -7,774 | -6,327 | -1,870 | Upgrade
|
| Interest Expense | - | -1,357 | -2,590 | -2,456 | -3,016 | Upgrade
|
| Interest & Investment Income | - | 1,246 | 692.21 | 323.74 | 116.41 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -9.87 | -26.54 | 45.02 | 27.8 | Upgrade
|
| Other Non Operating Income (Expenses) | -2,117 | 273.82 | -870.64 | -1,665 | 1,186 | Upgrade
|
| EBT Excluding Unusual Items | 12,711 | -5,246 | -10,569 | -10,079 | -3,557 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 3,203 | -117.01 | -3,605 | 3,290 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 27 | 292.49 | 13.04 | -0.27 | Upgrade
|
| Asset Writedown | - | - | -577.53 | -3,067 | -386.94 | Upgrade
|
| Other Unusual Items | - | - | 5.46 | -609.29 | - | Upgrade
|
| Pretax Income | 12,711 | -2,016 | -10,966 | -17,348 | -653.84 | Upgrade
|
| Income Tax Expense | - | 59.55 | -3,692 | -129.71 | 340.54 | Upgrade
|
| Earnings From Continuing Operations | 12,711 | -2,076 | -7,274 | -17,218 | -994.39 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -265.93 | -4,400 | - | Upgrade
|
| Net Income to Company | 12,711 | -2,076 | -7,540 | -21,618 | -994.39 | Upgrade
|
| Minority Interest in Earnings | - | - | -0 | 0 | 0.01 | Upgrade
|
| Net Income | 12,711 | -2,076 | -7,540 | -21,618 | -994.38 | Upgrade
|
| Net Income to Common | 12,711 | -2,076 | -7,540 | -21,618 | -994.38 | Upgrade
|
| Shares Outstanding (Basic) | - | 51 | 40 | 33 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | - | 51 | 40 | 33 | 25 | Upgrade
|
| Shares Change (YoY) | - | 28.44% | 21.80% | 28.46% | 40.00% | Upgrade
|
| EPS (Basic) | - | -40.51 | -189.00 | -660.00 | -39.00 | Upgrade
|
| EPS (Diluted) | - | -40.51 | -189.00 | -660.00 | -39.00 | Upgrade
|
| Free Cash Flow | - | -9,134 | -956.01 | -43,177 | -16,067 | Upgrade
|
| Free Cash Flow Per Share | - | -178.27 | -23.96 | -1318.23 | -630.15 | Upgrade
|
| Gross Margin | 100.00% | 18.46% | 12.09% | 18.58% | 26.70% | Upgrade
|
| Operating Margin | 33.48% | -11.62% | -18.55% | -13.41% | -4.44% | Upgrade
|
| Profit Margin | 28.70% | -4.46% | -17.99% | -45.80% | -2.36% | Upgrade
|
| Free Cash Flow Margin | - | -19.65% | -2.28% | -91.49% | -38.10% | Upgrade
|
| EBITDA | - | -1,635 | -3,859 | -2,060 | 608.49 | Upgrade
|
| EBITDA Margin | - | -3.52% | -9.21% | -4.37% | 1.44% | Upgrade
|
| D&A For EBITDA | - | 3,764 | 3,915 | 4,267 | 2,479 | Upgrade
|
| EBIT | 14,829 | -5,399 | -7,774 | -6,327 | -1,870 | Upgrade
|
| EBIT Margin | 33.48% | -11.62% | -18.55% | -13.41% | -4.44% | Upgrade
|
| Advertising Expenses | - | 921.87 | 150.94 | 975.62 | 1,202 | Upgrade
|
Updated Nov 14, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.